Ester Fernandez-Salas

This inventor holds 76 USPTO granted patents and 25 published patent applications, plus 6 CIPO patents and 24 EPO patents, primarily in Clostridial Toxin Research (CPC class G01N). Top assignees: Allergan, Inc., University of Michigan, Other. Active years: 2007-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ester Fernandez-Salas. Retrieved from https://idiyas.com/inventor/ester-fernandez-salas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 76 (Patent Applications = 25)

% Patents Active = 56.6

CIPO Patents = 6 (Patent Applications = 12)

EPO Patents = 24 (Patent Applications = 28)

Average Co-Inventor Count = 4.6

ph-index = 19

Forward Citations = 1,046(Granted Patents)

Forward Citations (Not Self Cited) = 732(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Fullergon, CA (US) (2014)
Fullerton, CA (US) (2007 - 2019)
Ann Arbor, MI (US) (2014 - 2022)
San Mateo, CA (US) (2021 - 2022)

Company Filing History:

University of Michigan

patents

1 out of 834,601

Other

patents

Years Active: 2007-2024

Loading Chart...

Areas of Expertise:

Clostridial Toxins

Botulinum Neurotoxin

Activity Assays

Degradable Toxins

Protein Degraders

Immuno-Based Assays

FRET Assays

Modified Toxins

Targeting Capabilities

Endopeptidase

Serotype A

Post-Translational Modifications

76 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12145944 - Imidazopyrimidines as EED inhibitors and the use thereof (2024-11-19),

2. 11466028 - Fused 1,4-oxazepines as BET protein degraders (2022-10-11),

3. 11332518 - Immuno-based botulinum toxin serotype A activity assays (2022-05-17),

4. 11267822 - BET bromodomain protein degraders with cleavable linkers (2022-03-08),

5. 11261240 - Immuno-based botulinum toxin serotype A activity assays (2022-03-01),

6. 10900967 - Immuno-based retargeted endopeptidase activity assays (2021-01-26),

7. 10703806 - Immuno-based botulinum toxin serotype A activity assays (2020-07-07),

8. 10527620 - Method of detecting cleaved SNAP25 in tissue samples (2020-01-07),

9. 10501731 - Degradable clostridial toxins (2019-12-10),

10. 10451621 - Highly sensitive cell-based assay to detect the presence of active botulinum neurotoxin serotype-A (2019-10-22),

11. 10345306 - Immuno-based retargeted endopeptidase activity assays (2019-07-09),

12. 9943576 - Formulations of biologics for intravesical instillation (2018-04-17),

13. 9850476 - Degradable clostridial toxins (2017-12-26),

14. 9651553 - Immuno-based retargeted endopeptidase activity assays (2017-05-16),

15. 9297003 - Degradable Clostridial toxins (2016-03-29),

Title: The Innovative Mind of Ester Fernandez-Salas

Introduction: Ester Fernandez-Salas, a visionary inventor based in Fullerton, CA, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Ester Fernandez-Salas holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Ester Fernandez-Salas has worked with leading tech companies, research institutions, and universities to bring his ideas to life. His innovative solutions have revolutionized various industries, earning him recognition as a pioneer in his field.

Collaborations: Throughout his career, Ester Fernandez-Salas has collaborated with top engineers, scientists, and designers to develop cutting-edge products that have had a significant impact on society. His ability to work effectively in multidisciplinary teams has been key to his success.

Conclusion: Ester Fernandez-Salas continues to push the boundaries of innovation, inspiring the next generation of inventors to think outside the box and create solutions that shape the future. His passion for technology and dedication to making a difference make him a true trailblazer in the world of inventions.

Profile summary based on public USPTO records.